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Microextraction by packed sorbent (MEPS) has been evaluated for fast screening of drugs
of abuse with mass spectrometric detection. In this study, C8 (octyl-silica, useful for
nonpolar to moderately polar compounds), ENV (hydroxylated polystyrene-divinylben-
zene copolymer, for extraction of aliphatic and aromatic polar compounds), Oasis MCX
(sulfonic-poly(divinylbenzene-co-N-polyvinyl-pyrrolidone) copolymer), and Clean Screen
DAU (mixed mode, ion exchanger for acidic and basic compounds) were used as sorbents
for the MEPS. The focus was on fast extraction and preconcentration of the drugs with
rapid analysis using a time-of-flight (TOF) mass spectrometer as the detector with direct
analysis in a real-time (DART) source. The combination of an analysis time of less than 1
min and accurate mass of the first monoisotopic peak of the analyte and the relative
abundances of the peaks in the isotopic clusters provided reliable information for
identification. Furthermore, the study sought to demonstrate that it is possible to quantify
the analyte of interest using a DART source when an internal standard is used. Of all the
sorbents used in the study, Clean Screen DAU performed best for extraction of the analytes
from urine. Using Clean Screen DAU to extract spiked samples containing the drugs,
linearity was demonstrated for ecgonine methyl ester, benzoylecgonine, cocaine, and
cocaethylene with average ranges of: 65–910, 75–1100, 95–1200, and 75–1100 ng/mL (n  5),
respectively. The limits of detection (LOD) for ecgonine methyl ester, benzoylecgonine, cocaine,
and cocaethylene were 22.9 ng/mL, 23.7 ng/mL, 4.0 ng/mL, and 9.8 ng/mL respectively, using a
signal-to-noise ratio of 3:1. (J Am SocMass Spectrom 2009, 20, 891–899) © 2009 American Society
for Mass SpectrometryBiological samples such as plasma and urine aremuch more complex than many others due to thepresence of proteins, salts, acids, bases, and var-
ious organic compounds with similar chemistry to the
analytes of interest. As a result, the extraction methods
for biological samples have been difficult. If an unsuit-
able sample preparation method has been employed
before the injection, the entire analytical process can be
wasted. The purpose of sample preparation is (1) re-
moval of interfering substances to eliminate ion sup-
pression, (2) conversion of the analytes into a more
suitable form for injection, separation, and detection,
and (3) preconcentration of the analytes to improve
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doi:10.1016/j.jasms.2009.01.010sensitivity. The procedure must be highly reproducible,
with a high recovery of the target analytes. Microextrac-
tion by packed sorbent (MEPS) is a new miniaturized,
solid-phase extraction method that can be connected
online to a GC or LC system without any modifications.
In MEPS approximately 1 to 2 mg of the solid packing
material is packed inside a syringe (100 to 250 L) as a
plug or between the barrel and the needle (Figure 1a).
Sample preparation takes place on the packed bed,
which can be coated to provide selective and suitable
sampling conditions. This approach to sample prepara-
tion is very promising for many reasons: (1) it is easy to
use, (2) it can be fully automated as an online proce-
dure, (3) it is rapid, and (4) the cost of analysis is
minimal compared with conventional solid-phase ex-
traction. Hence, several drugs such as local anesthetics
and their metabolites [1–3], the anticancer drugs rosco-
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[4–7], the -blockers acebutolol and metoprolol [8], the
neurotransmitters dopamine and serotonin [9], and
methadone [10] have been extracted from biological
samples such as blood, plasma, or urine samples using
MEPS.
Direct analysis in real time (DART) was recently
introduced as a new ion source and takes place in open
air under ambient conditions. The DART source (Figure
1b) operates by exposing the sample to a gas stream
such as helium or nitrogen. Ionization is performed by
reaction of electronic or vibrionic excited-state species
[11–14] with reagent molecules and analytes. DART can
be used for the analysis of gases, liquids, or solids, and
is a useful tool for small molecules analysis, and not a
technique for the analysis of large biomolecules such as
proteins. The ionization mechanisms in the DART
source are complex and do not follow a single process.
Two of the known published mechanisms are penning
ionization [15, 16] and proton transfer from water
clusters [17, 18]. Penning ionization is when a metasta-
ble atom transfers energy to an analyte (M), resulting in
the formation of a molecular ion M. This process will
occur if the analyte molecule M has an ionization
energy less than the internal energy of the metastable
Figure 1. (a) A syringe (1) with a plunger (2) having a syringe
barrel (3) slide ably within the barrel and a hollow needle (6)
extending from the barrel through which needle the liquid sample
is drawn into the syringe barrel characterized in that a solid-phase
or coating material (4, 5) is provided in the syringe barrel (4) or
between the barrel and the needle (5). (b) Schematic of the direct
analysis in real time (DART) source showing (a) Gas inlet in the
source, (b) Needle electrode, (c) Perforated disk electrodes, (d) Gas
heater, (e) Grid electrode, (f) Sample, (g) Mass spectrometer
orifice.ion. For the proton transfer from water clusters to occurin producing an [M  H], the analyte (M) must have
a higher proton affinity than the ionized water cluster.
Desorption electrospray ionization (DESI) is another
open source ionization technique that was first intro-
duced around the sample time as DART [19]. DESI
forms ions from surfaces by exposure to electrosprayed
solvent in a very high velocity gas stream. The DART is
an atmospheric pressure glow discharge source, where
the discharge is initiated by applying a potential be-
tween a needle electrode and a ground counter elec-
trode [11, 12, 18]. The gas exits the glow discharge
region of the DART source through the perforated disk
electrode, gas heater, and a grid electrode (Figure 1b).
Ionization occurs when the DART gas makes contact
with the sample in the open gap between the DART
source outlet and the orifice of the mass spectrometer.
However, other glow discharge ionization techniques
[20, 21] operate by introducing sample vapor through
an orifice into a glow discharge region at reduced
pressure. Unlike DART, possible sample loss could
occur when introduced into a vacuum, and sample
damage is possible on direct exposure to an electrical
discharge.
Using DART alone for analysis of drugs of abuse at
levels detected by other GC/MS and LC/MS tech-
niques [22–33] is not achievable. Now, to improve the
sensitivity of DART, sample pretreatment is required to
preconcentrate the analytes because the current config-
uration does not have the highest transmission of ions
into the mass spectrometer. As a result, the manufac-
turer of DART has a new device to be used between the
DART source and the orifice of the mass spectrometer
[18, 34]. Preliminary data reported by the manufacturer
demonstrate a significant improvement in ion transmis-
sion. This improvement should have a significant im-
pact on this procedure as a screening or quantitation
method.
Cocaine (C), an alkaloid from the plant species
Erythroxylon coca, is one of the most widely abused
drugs and is widely cultivated in South America. It is
extensively metabolized to benzoylecgonine (BZE),
ecgonine methyl ester (EME), and ecgonine (E) by
plasma, liver esterases, and spontaneous chemical hy-
drolysis [35]. Evidence of enzymatic hydrolysis of C to
BZE has been demonstrated. C does slowly hydrolyze
to BZE in an aqueous solution at pH 7.4 or above [36].
BZE with a longer half-life than cocaine is of consider-
able importance in clinical and forensic toxicology ap-
plications. Cocaethylene (CE) is produced through
transesterification following concurrent use of cocaine
and ethanol [37]. It has been shown in pharmacokinetic
studies of cocaine that 85% to 90% of a cocaine dose is
recovered in the 24-h urine. The unchanged drug ac-
counts for 1% to 9% of the dose depending on the urine
pH, while BZE and EME account for 35% to 54% and
32% to 49%, respectively [38, 39]. However, forensic
samples could be from a first time or a chronic user. The
concentration of cocaine and metabolites can therefore
extend over a wide range, depending on many condi-
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analysis of complex matrices due to its selectivity and
sensitivity, and is often the reference method for anal-
ysis of drugs in biological matrices. However, in the
past decade, the use of LC/MS has significantly in-
creased for routine analysis because of its sensitivity
and affordability. Although several GC/MS methods
for cocaine and metabolites in urine and whole blood
have previously been developed and are being used in
the laboratory, these procedures are relatively time-
consuming, taking up to several hours [22–26]. Because
of the demand for speed, sensitivity, and less time-
consuming methods, several LC, LC/MS, and LC/
MS/MS methods have been developed over the past
decade [27–33]. Most of these methods require offline
solid-phase extraction, which requires approximately
0.5 to 2 mL of urine, plasma, or blood. Because of the
volume of sample required for the analysis, it is fre-
quently difficult to perform a repeat extraction. Al-
though LC/MS methods have helped to bring about a
significant increase in speed and sensitivity, the instru-
ment analysis time is still significant.
In this study, we describe a sample preparation
method, MEPS, that requires a few microliters of sam-
ple and an extraction time of less than 2 min. Because of
the small volume of sample needed for extraction,
repeated analysis can be done. With the extraction
performed within a few minutes, followed by analysis
taking less than 1 min, the result of a sample can be
rapidly determined. This method uses a high-resolution
time-of-flight mass spectrometer equipped with an at-
mospheric pressure ionization (API) interface that is
used to identify compounds with the combination of
accurate mass measurements and accurate isotopic
abundances. In the future, coupling this extraction to a
robotic autosampler and interfacing it with the DART/
TOF mass spectrometer will make this method fully
automated.
Experimental
Chemical and Reagent
Certified standards, 100 g/mL in methanol, of cocaine,
d3-cocaine, cocaethylene, d3-cocaethylene, benzoylecgo-
nine, ecgonine methyl ester, and d3-ecgonine methyl
ester were purchased from Cerilliant Corporation
(Round Rock, TX). A d5-benzoylecgonine standard
was purchased from Cambridge Isotope Laboratories
(Andover, MA).
Negative control urine was pooled from anonymous
volunteers at the laboratory. Methanol, methylene chlo-
ride, and 2-propanol were purchased from Fisher Sci-
entific (Pittsburgh, PA). Monobasic sodium phosphate
and formic acid were purchased from Sigma Aldrich
(St. Louis, MO). Dibasic sodium phosphate, ammonium
hydroxide, and hydrochloric acid were purchased fromFisher Scientific Corporation (Fair Lawn, NJ). Deion-
ized water (18Mcm1 grade) was obtained from an
in-house Millipore purification system. Clean Screen
DAU solid-phase extraction material was purchased
from United Chemical Technologies Inc. (Bristol, PA).
Oasis MCX was purchased from Waters Corporation
(Milford, MA). The C8 and ENVwere purchased from
Argonaut (Mid Glamorgan, United Kingdom).
Instrumentation
The mass spectrometer used was a JMS-100TLC
(AccuTOF) atmospheric pressure ionization time-of-
flight mass spectrometer (JEOL USA, Peabody, MA),
operated in the positive mode with a resolving power in
excess of 6000 (FWHM definition). For all analyses, the
orifice 1 voltage of the atmospheric interface was set to
30 V and the ring lens and orifice 2 voltage were set to
5 and 10 V, respectively. A temperature of 80 °C was
applied to the orifices (Figure 1b). The RF ion guide
potential was set to 600 V. Data acquisition was set to
acquire m/z from 60 to 600. The DART ion source was
operated with helium gas at a flow rate of approx. 3.25
L/min during measurement. The source was purged
with nitrogen when it was not being used. The gas
heater was set to 400 °C for all analyses. The discharge
needle electrode, perforated disk electrodes, and the
grid electrode were set to 4000 V, grounded, 250 V, and
75 V, respectively. The discharge needle electrode,
perforated disk electrodes, grid electrode, and the
gas heater temperature were optimized for the best
response.
The mass scale calibration was accomplished by
placing neat polyethylene glycol, with an average mo-
lecular weight of 600, on a melting tube and passing it
in front of the source for a few seconds. There was no
memory effect or carryover of the reference compound
after the polyethylene glycol had been removed. As a
result, a full reference mass spectrum could be included
in each data file, and accurate mass measurements
could be accomplished for all samples. Before the
introduction of the sample to the DART source, a few
seconds of data were collected as the background. The
time collected for the background was subtracted from
the time for the sample to produce the spectrum of the
sample.
Preparation of Samples
Stock solutions of C, BZE, EME, and CE were prepared
in methanol with concentrations of 1200, 510, 450, and
520 g/mL, respectively. From the stock solutions,
intermediate standard solutions were made in urine for
C, BZE, EME, and CE with the concentrations 6.10, 5.10,
4.50, and 5.20 g/mL, respectively. An internal stan-
dard stock solution of d3-C, d5-BZE, d3-EME, and d3-CE
with concentrations of approximately 50 g/mL was
prepared in methanol.
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and the internal standard stock solution, an eight-point
standard curve was prepared from urine samples with
concentrations ranging from 45 to 2400 ng/mL in urine,
depending on the analyte, with an internal standard
concentration of 1000 ng/mL. All the solutions were
then diluted 1:1 with 0.1 M phosphate buffer (pH 6.0).
Using these solutions, a standard curve ranging from 20
to 1200 ng/mL, with an internal standard concentration
of 500 ng/mL, was prepared. Likewise, spiked samples
were diluted with phosphate buffer.
Figure 2. (a) Mass spectrum obtained with DAR
MEPS/Clean Screen DAU sorbent. (b) Mass spe
spiked with cocaine, cocaethylene, benzoylecgo
ng/mL, 458 ng/mL, and 515 ng/mL, respectively.Sample Extraction and Preconcentration
For this study, several solid-phase extraction (SPE)
sorbents were evaluated for the extraction of cocaine
and its metabolites from urine. The SPE sorbents used
for this study were C8, ENV, Oasis MCX, and Clean
Screen DAU. Since several different SPE materials were
used in this study, two extraction procedures were used
to maximize extraction efficiency and minimize car-
ryover. The SPE materials were packed in individual
250 L syringes. Sample preparation included the fol-
OF of a blank urine sample. Sample preparation:
obtained with DART/TOF of a urine sample
and ecgonine methyl ester at 611 ng/mL, 525T/T
ctrum
nine,
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and, finally, analyte elution. Before the extraction pro-
cedure, the C8 syringe was conditioned with 250 L
methanol, and twice with 250 L water. The urine
sample was drawn over the SPE material and dispensed
several times to improve the extraction. The syringe
was then washed with 250 L water and the analytes
were eluted with 100 L of a mixture of methylene
chloride/2propanol/ammonium hydroxide (79.5:20:0.5).
The syringe was cleaned three times with 250 L
methanol containing 0.5% ammonium hydroxide, then
twice with 250 L 100% water, twice with 250 L
methanol containing 0.5% formic acid, and, finally,
twice with 250 L water.
Before the extraction procedure, the syringes con-
taining ENV, Oasis MCX, and Clean Screen DAUwere
conditioned with 250 L of methylene chloride/2-
propanol/ammonium hydroxide (78:20:2) (eluting sol-
vent), then twice with 250 L methanol, twice with 250
L water, and, finally, with 250 L of 0.1 M phosphate
buffer. The urine sample was then drawn over the SPE
sorbent, the same procedure as for the C8 sorbent. The
syringe was then washed with 250 L water followed
by 100 L eluting solvent. Finally, cleaning was done
three times with 250 L methanol containing 2% am-
monium hydroxide, twice with 250 L water, twice
with 250 L methanol containing 2% formic acid, and,
finally, twice with 250 L water.
Sample Analysis
Five L of the extracted sample was added to the tip of
a melting tube and placed immediately in front of the
DART source. Within 1 min the analysis was completed
and a new sample could be introduced using a new tip.
Results and Discussion
The procedure described here was carried out with the
intention of achieving rapid screening of samples with
minimal sample preparation. Analyzing the sample
directly in the matrix produces unacceptable results,
with a poor response for all the analytes (Figure 2a and
b). This could be due to a combination of issues such as
ion suppression and the distribution of the total mass
present in the open source. Additionally, the depletion
of the metastable atoms (critical for ionization) by other
compounds in the complex matrix could limit the
ionization of the analytes. The matrix and low concen-
tration of drugs and their metabolites always present a
challenge to screening methods. In this article, we
describe MEPS as a good tool for drug screening. MEPS
can be used for the extraction and preconcentration of
metabolites and the parent drugs from urine and
plasma. In developing a screening method, several SPE
sorbents (C8, ENV, Oasis MCX, and Clean Screen
DAU) were evaluated. The purpose of the sample
preparation is (1) removal of interfering substances to
eliminate ion suppression, (2) conversion of the ana-Figure 3. Mass spectrum obtained with DART/TOF of a urine
sample spiked as in Figure 2, utilizing different sorbents (C8,
ENV, Oasis MCX, and Clean Screen DAU).
ept (
896 JAGERDEO AND ABDEL-REHIM J Am Soc Mass Spectrom 2009, 20, 891–899lytes into a more suitable form for injection, separation,
and detection, and (3) preconcentration of the analytes
to improve the sensitivity. The procedure must be
highly reproducible, with a high recovery of the target
analytes. The availability of cleaner and more reproduc-
ible sorbents, together with the large choice of sorbents
over past years, has helped the increasing acceptance of
and growing interest in SPE. There have been several
reports of the application of SPE techniques to a wide
variety of drugs and matrices.
Preconcentration in MEPS Using
Various Sorbents
The most important parameters in SPE are the selection
of the type and amount of the sorbent, the determina-
tion of the sample volume that can be applied without
loss in recovery, the composition and volume of the
washing solution that can be applied without loss of the
analytes, and finally the composition and volume of
the elution solution [40]. Silica-based sorbents such as
C8 can contain a low concentration of ionized silanol
groups capable of retaining basic solutes by an ion-
exchange mechanism. Thus, neutral and acidic com-
pounds are absorbed onto the silica sorbent through
hydrophobic interactions, whereas basic drugs are
bound through both hydrophobic and ionic interac-
tions. Copolymeric sorbents and mixed-mode sorbents
such as Clean Screen DAU contain hydrophobic and
ion-exchange functional groups. Mixed-mode sorbents
have been developed for the isolation of most drugs of
abuse and for classifying extracts into acid/neutral and
basic drugs for systematic toxicological analysis.
The MEPS (C8) sorbent extracted cocaine, cocaethyl-
ene, a trace amount of benzoylecgonine, and no ecgo-
nine methyl ester (Figure 3). Extraction using the ENV
showed the presence of all the analytes, though at a
much lower extraction efficiency than the C8 material.
The signal to noise was also much better using this
material than the C8 (Figure 3). The Oasis MCX pro-
duced results that demonstrate the presence of all the
analytes at a much higher efficiency and improved
signal to noise than the ENV, though lower than the
C8 (Figure 3). The SPE material that works best is the
Clean Screen DAU material, which shows the presence
of all the analytes with excellent signal to noise and
mass accuracy compared with the other materials (Fig-
ure 3). Although the results were acceptable, the extrac-
tion efficiency of cocaine and cocaethylene were far
Table 1. Regression parameters*
Ecgonine methyl ester Benzoyle
R2 (n  6) 0.992 0.9
Slope 0.00106  0.00051 0.00298 
Intercept 0.0141  0.0081 0.0126 
*Average line equation y  Average slope ( 3SD) X  Average intercmore effective than benzoylecgonine and ecgoninemethyl ester. This is due to the higher hydrophobicity
of cocaine and cocaethylene, resulting in higher inter-
action and higher extraction efficiency for these com-
pounds. The combination of MEPS for the extraction
and detection with DART/TOF has proven successful.
The extraction of the analytes from the matrix was
achieved within a few minutes, followed by analysis
that takes less than 1 min. Moreover, having a TOF
mass spectrometer as the detector has provided an
accurate mass of the analyte and its isotopes for defin-
itive confirmation. Having an instrument that requires
little or no sample preparation, combined with accurate
mass measurements, provides speed and specificity
that is always aspired to in forensic investigations. In
this experiment, in the positive ionization mode, C,
BZE, EME, CE, d3-C, d5-BZE, d3-EME, and d3-CE were
protonated to produce ions of the form [M  H] with
m/z 304.1548, 290.1392, 200.1286, 318.1705, 307.1737,
295.1706, 203.1475, and 321.1893, respectively. The iso-
topes of C, BZE, EME, CE, d3-C, d5-BZE, d3-EME, and
d3-CE were monitored with m/z 305.1581, 291.1425,
201.1318, 319.1738, 308.1769, 296.1738, 204.1507, and
322.1926, respectively. The guidelines used for the pres-
ence of a compound are the accurate mass of the analyte
and its isotopes, with mass errors less than 10 mmu, and
its isotopic relative abundance. The number of possible
elemental compositions generated for the average mass
of the protonated molecule of cocaine and each of its
metabolites was 1 when the following limits were
applied: the elemental composition limits were C0–20,
H0–42, N0–1, O0–6 and the mass tolerance was set to 10
mmu. For additional confirmation, ramping the cone
voltage (30 to 100 V) in the source of the mass spec-
ine Cocaine Cocaethylene
0.991 0.991
0051 0.00349  0.00168 0.00246  0.00015
423 0.0071  0.0192 0.01013  0.01062
 3SD).
Table 2. The accuracy at various concentrations in urine samples
Analyte
Concentration
(ng/mL)
Mean
concentration
(n  3)
Mean
accuracy %
(n  3)
Ecgonine methyl
ester
229 260 113
458 526 114
916 1065 116
Benzoylecgonine 257 238 93
515 534 104
1030 1059 103
Cocaine 305 333 109
611 611 100
1222 1215 100
Cocaethylene 262 276 105
525 526 100cgon
95
0.0
0.01049 1076 103
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MS/MS spectra give the accurate mass of the analyte
and its fragments.
Linear Range, Accuracy, and Selectivity
In this study, an attempt was made to demonstrate that
quantitation is possible using the combination of
MEPS/DART/TOF if an internal standard is used.
Standard curves were prepared in urine, extracted, and
analyzed on the DART/TOF. For the construction of the
calibration curve, 6 to 8 levels in human urine were
used for the studied analytes. Linearity was demon-
strated for ecgonine methyl ester, benzoylecgonine,
cocaine, and cocaethylene in the average ranges 65 to
920 ng/mL, 75 to 1100 ng/mL, 95 to 1200 ng/mL, and
75 to 1100 ng/mL (n  5), respectively. The concentra-
tion of the internal standard was 500 ng/mL. The data
presented in Table 1 reveal that a good linear relation-
ship was obtained. The results show a close correlation
Table 3. Accuracy at the lower limit of quantification (LLOQ)
Analyte
Concentration
ng/mL
Mean
concentration
ng/mL (n  5)
Mean
accuracy %
(n  5)
Ecgonine methyl
ester
65 75.4 116
Benzoylecgonine 75 65.8 87.7
Cocaine 95 89.4 94.1
Cocaethylene 75 76.3 102
Table 4. Comparison of LOD, LLOQ extraction and analysis tim
and its metabolites
Cocaine Cocaethylene Be
LOD (ng/mL) * *
75 *
* *
1 1
4 10
LOQ (ng/mL) 500 *
220 *
10 *
10 10
95 75
Extraction time (h) 2 *
2 *
2 *
2 2
0.02 0.02
Analysis time (min) 7 *
28 *
11 *
33 33
1 1
Accuracy of LOQ (%) 100 *
86 *
104 *
102 100
94 102*No published data.between the concentrations and relative peak areas for
the analytes studied.
The method was validated using quality-control
samples at three concentration levels. The accuracy
varied from 113% to 116% for ecgonine methyl ester,
93% to 104% for benzoylecgonine, 99.5% to 109% for
cocaine, and 100% to 105% for cocaethylene. The results
obtained are listed in Table 2.
A urine sample spiked with a mixture of analytes
and the internal standard was analyzed and compared
with an extracted urine blank. No significant interfer-
ence was detected from the extracted urine blank sam-
ple. Representative mass spectra of blank urine and
spiked urine sample are presented in Figure 3a and b.
Limit of Detection (LOD) and Lower Limit of
Quantitation (LLOQ)
The LODs for ecgonine methyl ester, benzoylecgonine,
cocaine, and cocaethylene were 22.9, 23.7, 4.0, and 9.8
ng/mL, respectively using a signal-to-noise ratio of 3:1.
The LLOQs for ecgonine methyl ester, benzoylecgonine,
cocaine, and cocaethylene were 65, 75, 95, and 75
ng/mL, respectively, using a signal-to-noise ratio 10.0.
The variation in accuracy of the LLOQ for cocaine and
metabolites was in the range of 16% of the nominal
concentration values (Table 3). The results showed close
correlation coefficients (0.99) for all analytes in the
calibration range studied.
d accuracy between this study and earlier studies for cocaine
lecgonine Ecgonine methyl ester Reference/method
* * [30] (GC/MS)
5 90 [31] (LC/UV)
* * [22] (GC/MS)
1 * [32] (LC/MS)
4 23 Present study
0 500 [30] (GC/MS)
0 260 [31] c(LC/UV)
0 10 [22] (GC/MS)
0 * [32] (LC/MS)
5 65 Present study
2 2 [30] (GC/MS)
2 2 [31] (LC/UV)
2 2 [22] (GC/MS)
2 * [32] (LC/MS)
0.02 0.02 Present study
7 7 [30] (GC/MS)
8 28 [31] (LC/UV)
1 11 [22] (GC/MS)
3 * [32] (LC/MS)
1 1 Present study
6 96 [30] (GC/MS)
7 87 [31] (LC/UV)
4 107 [22] (GC/MS)
8 * [32] (LC/MS)
8 107 Present studye an
nzoy
3
2
50
10
1
1
7





2
1
3

9
8
10
9
8
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The results of the present study were compared with
the results from the literature (Table 4). The results from
this study are in close agreement with earlier published
data. Furthermore, this method reduced the extraction
time by hundred times and analysis time was reduced
by tenfold compared with earlier studies. This work
demonstrates that quantitation can be performed on an
open source mass spectrometer with very short extrac-
tion and analysis times. The sensitivity of the present
method is high in comparison to the published methods
(Table 4). As a result, the manufacturer of the DART has
a new device to be used between the DART source and
the orifice of the mass spectrometer [18, 34]. This
method was intended to be used as a quick screening
method. However, the authors have gone to great
lengths to demonstrate that an open source can be used
for quantitation.
Conclusions
This study has demonstrated that the combination of
MEPS with DART/TOF can be a very useful tool for
screening drugs of abuse in a biological matrix. MEPS
can be used for the extraction and preconcentration of
metabolites and the parent drugs from the biological
matrices. The combined speed of extraction and detec-
tion performed within a few minutes is too striking to
be ignored. The accurate mass of the analyte and its
isotopes provides greater confidence in identification.
The study demonstrates that it is possible to quantitate
an analyte if a suitable internal standard is used em-
ploying MEPS/DART/TOF. Furthermore, having the
extraction material in a syringe lends itself to automa-
tion and, when interfaced with the DART/TOF, could
provide a completely automated system.
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